Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM, Lasho T.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH.
J Clin Oncol. 2018 Jan 20;36(3):231-237. doi: 10.1200/JCO.2017.74.7162. Epub 2017 Nov 1.
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S, Hasserjian RP, Hobbs G.
Curr Opin Hematol. 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565.
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT, Tyner JW, Gotlib J.
Curr Hematol Malig Rep. 2017 Oct;12(5):432-441. doi: 10.1007/s11899-017-0413-y.
BCR-ABL gene variants.
Melo JV.
Baillieres Clin Haematol. 1997 Jun;10(2):203-22. doi: 10.1016/s0950-3536(97)80003-0.
Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome.
Montefusco E, Alimena G, Lo Coco F, De Cuia MR, Wang YZ, Aloe Spiriti MA, Mancini F, Cedrone M, Mancini M, Mandelli F.
Ann Hematol. 1992 Jul;65(1):17-21. doi: 10.1007/BF01715120.
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F, Ball G, Kantarjian HM, Smith TL, Glassman A, Albitar M, Scappini B, Rios MB, Keating MJ, Beran M.
Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832.
Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemia.
O'Hare T, Eide CA, Deininger MW.
J Natl Cancer Inst. 2008 Jul 2;100(13):908-9. doi: 10.1093/jnci/djn204. Epub 2008 Jun 24.
Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Kim SY, Song IC, Kim J, Kwon GC.
Ann Diagn Pathol. 2024 Aug;71:152317. doi: 10.1016/j.anndiagpath.2024.152317. Epub 2024 Apr 18.
Update on CML-Like Disorders.
Cross NCP.
Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S101-S102. doi: 10.1016/S2152-2650(20)30477-8.
